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adequate patient preparation in terms of dietary restrictions
which could impede test accuracy. There were inconsistencies
among physicians regarding when in a patient’s life to initiate
screening, and at what age to discontinue screening. CONCLU-
SIONS: This systematic review of ten included studies reﬂected
considerable knowledge gaps among physicians, which could
contribute to reasons for inadequate screening rates. Provider
education about CRC screening should emphasize guidelines
regarding when to start screening, frequency rates for screening
with given modalities, and particular techniques and precautions
that should be used to perform screening.
PCN21
RETRANSFORMATION OF ESTIMATED LOG-TRANSFORMED
COSTS WHEN THE ERRORS PRESENT HETEROSKEDASTICITY
Baser O
Medstat, Inc, Ann Arbor, MI, USA
OBJECTIVE: Log transformation reduces robustness by focus-
ing on symmetry. It improves precision and it diminishes the
outlier effect. One big disadvantage of log models is retrans-
formation problems. Although smearing methods provides 
non-parametric way to transform estimated costs, it fails to
adjust heteroskedasticity especially if the form of heteroskedas-
ticity is not known. In this paper, we propose a method where
we can apply transformation accounting for heteroskedasticity.
We compare our results with smearing estimators and general-
ized linear model (GLM) estimators. METHODS: Two form of
heteroskedasticity is considered: 1) The heteroskedasticity is
known up to a multiple constant. We used generalized least
squares (GLS) estimator for correcting heteroskedasticity: and 2)
The form of heteroskedasticity is unknown. If this is the case,
feasible GLS method is used. After correcting for heteroskedas-
ticity smearing estimates is applied for the transformed equations
to do the retransformation. Medstat Market Scan data is used
to show the application. Cost level estimators are compared:
OLS estimation, smearing transformation assumed no het-
eroskedasticity, smearing transformation with heteroskedasticity,
GLM estimators where the family is gaussian with logarithmic
link function. RESULTS: Estimation methods yield that log scale
residuals were heavy tailed. White Test suggested the presence of
heteroskedascity. The graph of squared residuals on disease stage
levels show that variance is increasing with an increased level of
stage levels. Park test suggested that if GLM is chosen, gaussian
family should be chosen. Comparisons of the retransformed
costs yield that smearing transformation after accounting for
least deviation yielded least minimum square errors. CONCLU-
SION: We attempted to solve the biggest disadvantage of log
transformed cost estimation by proposing two stage estimation
procedure where at the ﬁrst stage GLS or feasible GLS is used to
correct for possible heteroskedasticity (depending on the form 
of heteroskedasticity), at the second stage smearing method is
applied to transformed equation.
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OBJECTIVE: Censoring is common problem with medical count
data. Estimation over only uncensored patients yields bias
toward the patients who have shorter survival time since patients
who have longer survival times are high likely to be censored.
Standard survival analysis is not applicable since the number of
visits during the study time and after censoring time is not inde-
pendent. The objective of this paper is to propose a method,
which can be applied to censored count data. METHOD: The
proposed method ﬁrst estimates the probability of censoring 
by using logit model. Then, second stage involves estimating
weighted Poisson regression where weights are calculated as
inverse of estimated probability of censoring. We show that the
resulting estimators are consistent. Standard errors from second
stage are not valid and should be adjusted for ﬁrst stage estima-
tion. We estimate the errors by using bootstrapping techniques.
RESULTS: Medstat Market Scan data is used as an application
of the method. Total hospitalization days after a year of initial
diagnoses is estimated. Patients who are diagnosed less than a
year before the end of study period are considered as censored.
After using inverse probability weighted poisson regression, we
also estimate the total hospitalization days by dropping the
patients whose visits are censored. A test is proposed to compare
the coefﬁcients. We found that the difference in coefﬁcients are
signiﬁcant (p < 0.0004). CONCLUSION: This paper presents a
method for testing and correcting for possible sample selection
bias for cross sectional data. In our application we assessed the
inﬂuence of explanatory variables, such as patient and clinical
characteristics, on inpatient visits of asthma two years following
diagnosis after accounting for possible selection bias due to 
censoring. We applied poisson and our proposed method and 
to show that failing to do the adjustments yield different 
estimators.
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OBJECTIVES: To assess inter-rater agreement of Health Utilities
Index (HUI) measurements in survivors of cancer during child-
hood in Honduras, El Salvador, Nicaragua and Panama.
METHODS: Patients and their parents completed a Spanish-
language interviewer-administered HUI questionnaire. Physi-
cians answered the Spanish-language self-complete questionnaire
version. Primary analyses of agreement between patients and
parents, and patients and physicians, for HUI3 single-attribute
and overall health-related quality of life (HRQL) utility scores
was measured using single-measure one-way intra-class correla-
tion coefﬁcient (ICC). Secondary analyses used the two-way
mixed model ICC, Pearson’s r and concordance correlation coef-
ﬁcient. Differences in mean scores > 0.05 are considered clini-
cally important. RESULTS: Of 211 patients surveyed (aged 3.4
to 25.8 years at time of study, 56% male), there were 191
patient/parent pairs of complete HUI assessments and 192
patient/physician pairs. There was moderate or better agreement
(ICC > 0.41, p < 0.001) between both pairs of raters for vision,
hearing, speech and ambulation. Agreement was less than mod-
erate (ICC < 0.41) for pain (p < 0.01), cognition (p < 0.01) and
emotion (p < 0.05). Statistically signiﬁcant (p < 0.001) and clin-
ically important differences were observed within both sets of
paired groups for cognition and emotion, with lower mean
scores for patients. For overall HRQL, agreement was moderate
between patients and parents but less than moderate between
patients and physicians. The mean overall HRQL score was sig-
niﬁcantly lower statistically (p < 0.01) and clinically for patients
than both parents (diff = 0.094), and physicians (diff = 0.159).
Secondary analyses yielded similar results. CONCLUSIONS:
Parent and physician reports should not be considered inter-
changeable with patient assessments, especially for aspects of
health not readily observable. There were important differences
between patients and parents and physicians in emotion, cogni-
